Are optimal levels of testosterone associated with better cognitive function in healthy older women and men?

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 10, 2010, Pages 1145-1152

  Hogervorst, Eef ^a   Matthews, Fiona E ^b   Brayne, Carol ^c  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cognition; Estrogen; Sex hormone binding globulin; Testosterone; Thyroid hormones

Indexed keywords

ESTROGEN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROID HORMONE;

ADULT; AGED; AGING; ARTICLE; AUTOMATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TESTOSTERONE BLOOD LEVEL; WORKING MEMORY; BLOOD; CLINICAL TRIAL; MEMORY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION; DEMENTIA; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 77956169573     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.12.009     Document Type: Article

References (63)

1. Barrett-Connor E. Rethinking estrogen and the brain. JAGS 1998, 46:918-920.
2. Shumaker S.A., Legault C., Rapp S.R., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 2003, 289:2651-2662.
3. Shumaker S.A., Legault C., Kuller L., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24):2947-2958.
4. Hogervorst E., Barnetson L., Williams J., Budge M., Dowsett M., Smith A.D. Women with dementia of Alzheimer's type have higher levels of estradiol than healthy controls: prize winning poster. Paper presented at: The 5th Annual Graylyn Conference on Women's Health 1999, Winston-Salem.
5. Brinton R.D. The healthy cell bias of estrogen action. Trends Neurosci. 2008, 31(10):529-537.
6. Ahlbom E., Prins G.S., Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001, 892:255-262.
7. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., LeBlanc A. Testosterone mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 2001, 77:1319-1326.
8. Pike C.J. Testosterone attenuates b-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001, 919:160-165.
9. Hogervorst E., Bandelow S., Lehmann D.L. Testosterone, gonadotrophins, & genetic polymorphisms in men with Alzheimer's disease. Hormones, Cognition and the Brain 2009, Cambridge University Press, Cambridge. E. Hogervorst, V.W. Henderson, R.D. Brinton-Diaz, R. Gibbs (Eds.).
10. Pike C.J., Rosario E.R. Testosterone regulates Alzheimer's disease pathogenesis. Hormones, Cognition and the Brain 2009, Cambridge University Press, Cambridge, Chapter 26. E. Hogervorst, V.W. Henderson, R.D. Brinton-Diaz, R. Gibbs (Eds.).
11. Hogervorst E., Bandelow S., Moffat S.D. Increasing testosterone levels and effects on cognitive function in elderly men and women. Curr. Drugs Targets: CNS Neurol. Dis. 2005, 4(5):531-540.
12. Hogervorst E., De Jager C., Budge M.M., Smith A.D. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology 2004, 29(3):405-421.
13. Lunenfeld B., Gooren L.J.G, Morales A., Morley J.E. Textbook of Men's Health and Aging 2007, 16. Informa Health Care. 2 ed.
14. Barrett-Connor E., Goodman-Gruen D., Patay B. Endogenous sex hormones and cognitive function in older men. JCEM 1999, 84(10):3681-3685.
15. Yaffe K., Lui L.Y., Zmuda J., Cauley J. Sex hormones and cognitive function in older men. JAGS 2002, 50(4):707-712.
16. Thilers P.P., Macdonald S.W., Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90year-old men and women. Psychoneuroendocrinology 2006, 31(5):565-576.
17. Fonda S.J., Bertrand R., O'Donnell A., Longcope C., McKinlay J.B. Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60(3):385-390.
18. Yonker J.E., Eriksson E., Nilsson L.G., Herlitz A. Negative association of testosterone on spatial visualization in 35 to 80year old men. Cortex 2006, 42(3):376-386.
19. Martin D.M., Wittert G., Burns N.R., Haren M.T., Sugarman R. Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas 2007, 57(2):182-194.
20. Muller M., Aleman A., Grobbee D.E., deHaan E.H., van der Schouw Y.T. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level. JCEM 2005, 90(5):2618-2623.
21. Yaffe K., Barnes D., Lindquist K., et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol. Aging 2007, 28(2):171-178.
22. Geerlings M.I., Strozyk D., Masaki K., et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann. Neurol. 2006, 60(3):346-355.
23. Lessov-Schlaggar C.N., Reed T., Swan G.E., et al. Association of sex steroid hormones with brain morphology and cognition in healthy elderly men. Neurology 2005, 65(10):1591-1596.
24. Moffat S.D., Zonderman A.B., Metter E.J., Blackman M.R., Harman S.M., Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. JCEM 2002, 87(11):5001-5007.
25. Wolf O.T., Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm. Behav. May 2002, 41(3):259-266.
26. Drake E.B., Henderson V.W., Stanczyk F.Z., McCleary C.A., Brown W.S., Smith C.A., Rizzo A.A., Murdock G.A., Buckwalter J.G. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 2000, 54:599-603.
27. Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol. Med. 1998, 28(2):319-335. MRC CFAS.
28. Pinto E.M., Huppert F.A., Morgan K., CFAS M.R.C., Brayne C. Neutrophil counts, monocyte counts and cardiovascular disease in the elderly. Exp. Gerontol. 1998, 39(4):615-619.
29. Folstein M., Folstein S., McHugh P. 'Mini-mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1977, 12:189-198.
30. Copeland J.R., Dewey M.E., Griffiths-Jones H.M. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol. Med. 1986, 16:89-99.
31. Townsend P. Poverty in the United Kingdom 1979, Pelican, U.K.
32. Hogervorst E., Huppert F., Matthews F.E., Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 2008, 33(7):1013-1022.
33. Lamph S., Wheeler M., Halloran S. DPC Immulite 2000 and immulite testosterone assays. Surrey: MHRA Evaluation Unit Royal Surrey County Hospital Trust 2004.
34. Jin M., Wener M.H., Bankson D.D. Evaluation of automated SHBG immunoassays. Clin. Biochem. 2006, 39(1):91-94.
35. Jones S., Small B.J., Fraiglioni L., Backman L. Predictors of cognitive change from preclinical to clinical Alzheimer's disease. Brain Cogn. 2002, 49(2):210-213.
36. Wechsler D. Manual for the Wechsler Memory Scale Revised 1987, The Psychological Corporation, San Antonio TX USA.
37. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations and pitfalls in measuring testosterone: an endocrine society position statement. JCEM 2007, 92(2):405-413.
38. Arver S., Lehtihet M. Current guidelines for the diagnosis of testosterone deficiency. Front. Horm. Res. 2009, 37:5-20.
39. Barrett-Connor E., Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. JAGS 1999, 47(11):1289-1293.
40. Yesufu A., Bandelow S., Hogervorst E. Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Women's Health 2007, 3(2):173-195.
41. Hogervorst E., Yaffe K., Richards M., Huppert F.A. HRT to maintain cognitive function in women with dementia. Cochrane Database Syst. Rev. 2009, 21(1):CD003799.
42. Hogervorst E., Bandelow S. Should surgically menopausal women be treated with estrogens to decrease the risk for dementia? Invited editorial. Neurology 2007, 69(11):1070-1071.
43. Bowen R.L., Isley J.P., Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer Disease?. J. Neuroendocrinol. Apr 2000, 12(4):351-354.
44. Bowen R.L., Smith M.A., Harris P.L., et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J. Neurosci. Res. 2002, 70(3):514-518.
45. Bowen R.L., Verdile G., Liu T., et al. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 2004, 279(19):20539-20545.
46. Casadesus G., Atwood C.S., Zhu X., et al. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell. Mol. Life Sci. Feb 2005, 62(3):293-298.
47. Casadesus G., Milliken E.L., Webber K.M., et al. Increases in LH are associated with declines in cognitive performance. Mol. Cell Endocrinol. 2007, 169(1-2):107-111.
48. Hogervorst E., Combrinck M., Lapuerta P., Rue J., Swales K., Budge M. The Hopkins Verbal Learning Test and screening for dementia. Dementia 2002, 13(1):13-20.
49. Moffat S.D., Zonderman A.B., Metter E.J., et al. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004, 62(2):188-193.
50. Hogervorst E., Williams J., Budge M., Barnetson L., Combrinck M., Smith A.D. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol. Lett. 2001, 22(3):163-168.
51. Fonda S.J., Bertrand R., O'Donnell A., Longcope C., McKinlay J.B. Age, hormones and cognitive function among middle-aged and elderly men. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 60:385-390.
52. Hogervorst E., Bandelow S., Combrinck M.C., Smith A.D. Low free testosterone is an independent risk factor for AD. Exp. Gerontol. 2004, 39(11-12):1633-1639.
53. Muller M., Schupf N., Manly J.J., Mayeux R., Luchsinger J.A. SHBG and incident AD in elderly men and women. Neurobiol. Aging Nov 18 2008, Electronic publication ahead of print.
54. Ravaglia G., Forti P., Maiolo F., et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62(9):1035-1041.
55. Den Heijer T., Geerlings M.I., Hofman A., et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch. Neurol. 2003, 60(2):213-220.
56. Muller M., van den Beld A.W., Grobbee D.E., de Jong F.H., Lamberts S.W. Sex hormones and cognitive decline in elderly men. Psychoneuroendocrinology 2009, 34(1):27-31.
57. Rosario E.R., Chang L., Stanczyk F.Z., Pike C.J. Age-related testosterone depletion and the development of Alzheimer disease. JAMA Sep 22 2004, 292(12):1431-1432.
58. Iivonen S., Corder E., Lehtovirta M., et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 2004, 62(7):1170-1176.
59. Krithivas L., Yurgalevitch S.M., Mohr B.A., et al. Evidence that the CAG repeat in the AR gene is associated with the age-related decline in serum androgen levels in men. J. Endocrin. 1999, 162(1):137-142.
60. Lehmann D.J., Hogervorst E., Warden D.R., Smith A.D., Butler H.T., Ragoussis J. The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men. JNNP 2004, 75(1):163-164.
61. Hogervorst E., Lehmann D.J., Warden D.R., McBroom J., Smith A.D. Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int. J. Geriatr. Psychiatry 2002, 17(10):938-940.
62. Peters R. The prevention of dementia. Int. J. Geriatr. Psychiatry 2009, 24(5):452-458.
63. Petitti D.B., Buckwalter J.G., Crooks V.C., Chiu V. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J. Gerontol. A Biol. Sci. Med. Sci. Aug 2002, 57(8):M532-M538.